Investors & Media 10-K

SEC Filing Details

Document Details

Form
Filing Date
Jun 11, 2018
Document Date
Mar 31, 2018
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Axovant Gene Therapies
Issuer
Axovant Gene Therapies Ltd.